- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nuformix PLC (NFXN)
Assess today's live Nuformix PLC (NFXN) share price, performance and insights using our live London: NFXN stock exchange data.
Analyse the historical data and Nuformix PLC share price performance charts on this page. Our technical summary section provides analysis on Nuformix share price buy/sell indicators using real-time data (or discuss the Nuformix (NFXN) stock price today with other investors in the Nuformix LON share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current LON NFXN share price (ISIN: GB00BYW79Y38) to enhance your trading decisions with our free investment tools and resources.
What Is the Nuformix PLC Share Price Today?
The Nuformix share price today is 0.3150.
What Is the Stock Symbol for Nuformix PLC
The stock symbol (or 'ticker') for Nuformix PLC is "NFXN."
What Stock Exchange Does Nuformix PLC Trade On?
Nuformix PLC is listed and trades on the London stock exchange.
Is Nuformix PLC a Good Stock to Buy?
Determining whether Nuformix PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Nuformix PLC share price performance charts on this page. Our technical summary section provides analysis on Nuformix share price buy/sell indicators using real-time data (or discuss the Nuformix (NFXN) stock price today with other investors in the Nuformix LON share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current LON NFXN share price (ISIN: GB00BYW79Y38) to enhance your trading decisions with our free investment tools and resources.
What Is the Nuformix PLC Share Price Today?
The Nuformix share price today is 0.3150.
What Is the Stock Symbol for Nuformix PLC
The stock symbol (or 'ticker') for Nuformix PLC is "NFXN."
What Stock Exchange Does Nuformix PLC Trade On?
Nuformix PLC is listed and trades on the London stock exchange.
Is Nuformix PLC a Good Stock to Buy?
Determining whether Nuformix PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
London
Currency in GBP
0.3150
-0.0200(-5.97%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3020
0.3500
52 wk Range
0.0420
0.5550
NFXN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.30200.3500
52 wk Range
0.04200.5550
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
NFXN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Nuformix delighted as NXP004 testing exceeds the company’s expectations
- Proactive Investors
- Nuformix delighted as NXP004 testing exceeds the company’s expectations
- Proactive Investors
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Nuformix Company Profile
Nuformix plc, together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. The company develops NXP001, which is in the Phase 1 stage for use in oncology supportive care; NXP002, which is in the pre-clinical stage for the treatment of idiopathic pulmonary fibrosis; and NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology. It has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Compare NFXN to Peers and Sector
Metrics to compare | NFXN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNFXNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −3.8x | −0.6x | |
PEG Ratio | 0.00 | 0.02 | 0.00 | |
Price/Book | 8.2x | 4.3x | 2.6x | |
Price / LTM Sales | - | 5.1x | 3.3x | |
Upside (Analyst Target) | - | 60.1% | 39.4% | |
Fair Value Upside | Unlock | −7.5% | 3.9% | Unlock |
Earnings
Latest Release
Dec 03, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Nuformix (NFXN) Share Price Today?
The live Nuformix share price today is 0.3150
What Stock Exchange Does Nuformix (NFXN) Trade On?
Nuformix is listed and trades on the London Stock Exchange.
What Is the Ticker (Stock Symbol) for Nuformix?
The stock symbol (also called a 'ticker') for Nuformix is "NFXN."
What Is the Current Nuformix Market Cap?
As of today, Nuformix market capitalisation is 6.65M.
What Is Nuformix's (NFXN) Earnings Per Share (TTM)?
The Nuformix EPS is currently -0.00 (Trailing Twelve Months).
When Is the Next Nuformix Earnings Date?
Nuformix's next earnings report will be released on 03 Dec 2025.
Is NFXN a Buy or Sell From a Technical Analyst Perspective?
Based on today's Nuformix moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Nuformix Stock Split?
Nuformix has split 0 times. (See the NFXN stock split history page for full effective split date and price information.)
How Many Employees Does Nuformix Have?
Nuformix has 3 employees.
What is the current trading status of Nuformix (NFXN)?
As of 08 Jan 2026, Nuformix (NFXN) is trading at a price of 0.3150, with a previous close of 0.3150. The stock has fluctuated within a day range of 0.3020 to 0.3500, while its 52-week range spans from 0.0420 to 0.5550.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.